Tag: Dr Anna M Wu
Telix secures advanced biologics technology platform in strategic deal
Telix Pharmaceuticals has announced an asset purchase agreement with antibody engineering firm ImaginAb, Inc, marking the expansion of its capabilities in precision medicine and therapeutic innovation.
Featured Article
What spending reveals about downstream consumer demand for manufactured goods
For manufacturers supplying consumer-facing markets, understanding demand conditions has become increasingly important in an environment shaped by cautious spending, rising costs and intense competition.
